Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Carducci

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center|January 5, 2002
NCCN: Palliative careM H Levy, S M Weinstein, M A Carducci, et al.
Urology|March 4, 2000
Management of patients with rising prostate-specific antigen after radical prostatectomyM Laufer, C R Pound, M A Carducci, et al.
Urology|February 7, 2001
Rapid disease progression after the administration of bicalutamide in patients with metastatic prostate cancerM Laufer, V J Sinibaldi, M A Carducci, et al.
In Vivo (Athens, Greece)|August 26, 1998
Allopurinol-induced pyrimidinuria in cancer patientsM A Carducci, M Choti, N E Maestri, et al.
Cancer Research|March 14, 2001
Combination of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and angiogenesisR Pili, M P Kruszewski, B W Hager, et al.
The Journal of Urology|June 7, 2000
Complete androgen blockade for prostate cancer: what went wrong?M Laufer, S R Denmeade, V J Sinibaldi, et al.
International Journal of Impotence Research|April 18, 2006
Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapyM Braga-Basaria, D C Muller, M A Carducci, et al.
Seminars in Oncology|December 1, 1996
Prostate cancer treatment strategies based on tumor-specific biological principles: future directionsM A Carducci, T L DeWeese, W G Nelson, et al.
Urology|March 1, 1995
Interleukin-6: a candidate mediator of human prostate cancer morbidityD A Twillie, M A Eisenberger, M A Carducci, et al.
British Journal of Cancer|December 3, 2011
Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumoursR Pili, B Salumbides, M Zhao, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Cancer Control : Journal of the Moffitt Cancer Center|January 5, 2002
NCCN: Palliative careM H Levy, S M Weinstein, M A Carducci, et al.
Urology|March 4, 2000
Management of patients with rising prostate-specific antigen after radical prostatectomyM Laufer, C R Pound, M A Carducci, et al.
Urology|February 7, 2001
Rapid disease progression after the administration of bicalutamide in patients with metastatic prostate cancerM Laufer, V J Sinibaldi, M A Carducci, et al.
In Vivo (Athens, Greece)|August 26, 1998
Allopurinol-induced pyrimidinuria in cancer patientsM A Carducci, M Choti, N E Maestri, et al.
Cancer Research|March 14, 2001
Combination of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and angiogenesisR Pili, M P Kruszewski, B W Hager, et al.
The Journal of Urology|June 7, 2000
Complete androgen blockade for prostate cancer: what went wrong?M Laufer, S R Denmeade, V J Sinibaldi, et al.
International Journal of Impotence Research|April 18, 2006
Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapyM Braga-Basaria, D C Muller, M A Carducci, et al.
Seminars in Oncology|December 1, 1996
Prostate cancer treatment strategies based on tumor-specific biological principles: future directionsM A Carducci, T L DeWeese, W G Nelson, et al.
Urology|March 1, 1995
Interleukin-6: a candidate mediator of human prostate cancer morbidityD A Twillie, M A Eisenberger, M A Carducci, et al.
British Journal of Cancer|December 3, 2011
Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumoursR Pili, B Salumbides, M Zhao, et al.
Pageof 5